title: Elimination on the agenda for hepatitis C.
authors: Talha
authors: T
authors: Burki
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D060740:Disease Eradication; D014943:Global Health; D006526:Hepatitis C / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007267:Injections / Q000592:standards; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*; D000069474:Sofosbuvir; D015819:Substance Abuse, Intravenous / Q000150:complications; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D014542:Uridine Monophosphate; D000069474:Sofosbuvir